Skip to content
Descubridor Institucional UMAR
Inicio
Búsqueda avanzada
Explorar
Inicio
Búsqueda avanzada
Explorar
Login
Language
English
Deutsch
Español
Français
Italiano
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Correction to “Amyloid ratios in plasma and CSF are biomarkers of pre‐symptomatic Alzheimer's disease”
Correction to “Amyloid ratios in plasma and CSF are biomarkers of pre‐symptomatic Alzheimer's disease”
Fuente:
Wiley Open Access
Saved in:
Bibliographic Details
Format:
Artículo Open Access
Published:
Wiley
2024
Subjects:
Alzheimer's & Dementia
Online Access:
Acceder al recurso
Tags:
Add Tag
No Tags, Be the first to tag this record!
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Save to List
Permanent link
Holdings
Description
Comments
Similar Items
Staff View
Internet
https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz.13738
Similar Items
Pharmacodynamic effects of semorinemab on plasma and CSF biomarkers of Alzheimer's disease pathophysiology
by: Stephen P. Schauer, et al.
Published: (2024)
CSF proteomic profiles of neurodegeneration biomarkers in Alzheimer's disease
by: Aurore Delvenne, et al.
Published: (2024)
Synaptic proteins in pre‐symptomatic Alzheimer's disease: genes implicate synaptic biomarkers to the early detection of cognitive decline
by: Jiarui Ao, et al.
Published: (2024)
Correspondence between borderline and inconclusive pre‐mortem CSF Alzheimer's disease biomarkers and post‐mortem Alzheimer's disease neuropathologic change
by: Molly A Mather, et al.
Published: (2025)
Detecting Amyloid–β Pathology in Subjective Cognitive Decline using novel CSF and plasma biomarkers
by: José Contador, et al.
Published: (2025)